volume 39, issue 40, P3654-3661 2018
DOI: 10.1093/eurheartj/ehy420
View full text
|
|
Share

Abstract: In a real-life setting, a comparison of the incidence of early CV events during antihypertensive monotherapy and FDC shows that the latter strategy leads to a more effective CV protection. This scores in favour of a two-drug FDC strategy as first step in the hypertensive population.